Voclosporin: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Voclosporin. Educational only — not medical advice.
Labeled uses
LUPKYNIS is indicated in combination with a background immunosuppressive therapy regimen [see Clinical Studies ( 14 )] for the treatment of adult patients with active lupus nephritis (LN). Limitations of Use: Safety and efficacy of LUPKYNIS have not been established in combination with cyclophosphamide. Use of LUPKYNIS is not recommended in this situation.
Source: FDA labeling via NIH DailyMed (set 9f489295…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.